Table 1

Characteristics of patients at baseline

5-year follow-up
(n=41)
8-year follow-up*
(n=12)
Gender distribution27 men, 14 women8 men, 4 women
Age at onset (mean±SD, years)43.3±9.840.4±9.8
Age at surgery (mean±SD, years)56.2±8.452.8±10.1
Disease duration (mean±SD years)12.9±5.812.3±4
L-dopa equivalent dose (LED)1471±5151475±525
  • *Baseline features between the total cohort and the patients followed beyond 8 years did not differ significantly.